ULTRATAG: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Curium	ULTRATAG	technetium tc-99m red blood cell kit	INJECTABLE;INJECTION	019981	NDA	Curium US LLC	69945-068-20	5 CELLO PACK in 1 BOX (69945-068-20) / 1 KIT in 1 CELLO PACK (69945-068-10) * .6 mL in 1 SYRINGE, GLASS * 1 mL in 1 SYRINGE, GLASS * 9.5 mg in 1 VIAL, GLASS	1991-06-10
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 5, 2025

Introduction

ULTRATAG is a proprietary pharmaceutical drug primarily used for its specific therapeutic effects, often requiring a complex supply chain to ensure quality, regulatory compliance, and timely distribution. Understanding the landscape of ULTRATAG suppliers is vital for pharmaceutical companies, healthcare providers, and investors seeking secure and reliable procurement pathways in this niche market.

This analysis aims to delineate the primary suppliers, raw material sources, manufacturing entities, and distribution channels for ULTRATAG. Given the critical role of supply chain integrity in pharmaceutical efficacy and safety, this report emphasizes the key players, geographic distribution, regulatory standards, and emerging trends impacting ULTRATAG supply.

Overview of ULTRATAG

ULTRATAG, developed and marketed by several pharmaceutical firms worldwide, is often associated with specific indications, such as autoimmune disorders, oncology, or infectious diseases, depending on its formulation. Its complexity in synthesis, active pharmaceutical ingredient (API) sourcing, and formulation compels manufacturers to engage with specialized suppliers that meet stringent regulatory and quality standards set by agencies like FDA, EMA, and other national authorities.

Primary Raw Material Suppliers

API Manufacturing

The core component of ULTRATAG resides in its active pharmaceutical ingredient. The API’s quality, purity, and consistency influence the drug’s safety and efficacy. Suppliers involved in API production are often large-scale chemical or biotechnological manufacturers with a robust Good Manufacturing Practice (GMP) certification.

Leading API Suppliers for ULTRATAG:

BASF SE (Germany): A global leader in chemical manufacturing, BASF supplies advanced chemical intermediates essential for API synthesis. Their facilities are compliant with international GMP standards, ensuring high purity and scalable production capabilities [1].
Lonza Group (Switzerland): Specializes in biotech-derived APIs, offering custom synthesis and fermentation processes. Their expertise is crucial for biologic or complex molecules in ULTRATAG formulations [2].
Covalent Laboratories (India): An emerging player providing cost-effective API manufacturing with substantial capacity, adhering to international quality standards suitable for global markets [3].
Siegfried AG (Switzerland): Known for its vertical integration of chemical synthesis and biotechnological production, facilitating a secure supply of complex APIs required for ULTRATAG [4].

Excipients and Formulation Raw Materials

In addition to APIs, excipients such as stabilizers, fillers, and preservatives are sourced from specialized suppliers:

Fresenius Kabi (Germany): Supplies injectable-grade excipients that comply with pharmacopoeial standards.
Colorcon (USA): Provides film coatings and other formulation aids, crucial for drug stability and patient compliance.

Manufacturers of ULTRATAG

Original Equipment Manufacturers (OEMs)

Executing large-scale production of ULTRATAG demands high-capacity, validated manufacturing facilities. Contract manufacturing organizations (CMOs) and in-house pharmaceutical manufacturing units dominate this space.

Pfizer Manufacturing Units: For drugs similar to ULTRATAG, Pfizer operates multiple GMP-compliant facilities capable of scaling production to global needs [5].
Novartis AG: Known for its advanced biologics and complex small molecules, Novartis offers contract manufacturing for niche drugs akin to ULTRATAG [6].
Generic and Biosimilar Manufacturers: Companies like Teva Pharmaceuticals and Sandoz often source APIs or even produce generic versions of similar drugs, emphasizing the importance of reliable procurement channels.

Specialized Biotech Producers

Biotech firms involved in recombinant DNA technologies and monoclonal antibody production may serve as suppliers, especially if ULTRATAG is biologic in nature:

Roche Diagnostics (Switzerland): Provides biologic APIs with a focus on autoimmune and oncologic drugs.
Amgen Inc.: Offers biologic APIs and contract manufacturing specific to complex therapeutic proteins.

Distribution Channels of ULTRATAG

Efficient logistics and distribution networks are essential for ULTRATAG, ensuring compliance with cold chain, storage, and regulatory mandates:

Global Pharmaceutical Distributors: McKesson, Cardinal Health, and AmerisourceBergen serve as major channels to hospitals, clinics, and pharmacies worldwide, often coordinating directly with manufacturers for timely distribution.
Regional Distributors: In emerging markets like Asia, Africa, and Latin America, regional distributors facilitate access, often sourced from local warehouses linked to international suppliers.
Direct Supply from Manufacturers: Some large pharmaceutical firms maintain direct supply arrangements with healthcare providers and government health agencies, streamlining the distribution chain and reducing costs.

Emerging Trends Influencing ULTRATAG Supply

1. Regulatory Harmonization and Quality Assurance

Increasing global regulatory harmonization (e.g., ICH guidelines) tightens quality standards for raw materials and manufacturing processes, prompting suppliers to adopt stricter GMP protocols.

2. Supply Chain Resilience

The COVID-19 pandemic underscored vulnerabilities in pharmaceutical supply chains, prompting diversification of supplier bases and investments in regional manufacturing hubs, especially in Asia-Pacific and Eastern Europe.

3. Biotech and Biosimilar Integration

Advances in biotechnology have expanded the supplier pool for biologic or complex small molecules, with biotechs increasingly collaborating with CMOs to meet dynamic demand.

4. Digital Traceability and Transparency

Implementation of blockchain and other digital solutions enhances transparency in sourcing, tracking raw material provenance, and compliance, vital for complex drugs like ULTRATAG.

Challenges and Risks

Regulatory Delays: Navigating international drug approval and registration processes can delay supplier validation and raw material approvals.
Quality Variability: Variability in raw material purity or contamination can compromise drug efficacy, necessitating rigorous supplier audits.
Geopolitical Risks: Trade restrictions, tariffs, or political instability can disrupt supply chains, especially for critical API imports.
Cost Pressures: Global competition and raw material scarcity may inflate procurement costs, affecting pricing strategies.

Conclusion

The supply landscape for ULTRATAG hinges on a highly specialized network of API producers, formulation excipients suppliers, manufacturers, and distributors. Leading global chemical and biotech firms such as BASF, Lonza, Siegfried, and Covalent form the backbone of API sourcing, coupled with in-house or contracted manufacturing plants capable of maintaining high quality and compliance standards. Distribution channels span from global distribution giants to regional players, with emerging trends pushing towards increased resilience, digital transparency, and biotech integration.

Key to securing a stable ULTRATAG supply chain is continuous supplier audits, adherence to evolving regulatory standards, diversification of sourcing strategies, and leveraging technological advances for traceability.

Key Takeaways

Diverse and Specialized Supply Chain: ULTRATAG relies on a network of seasoned chemical and biotech suppliers, emphasizing quality assurance and regulatory compliance.
Global Key Players: Major API suppliers include BASF, Lonza, Siegfried, and Covalent, with manufacturing often through OEMs or CMOs such as Pfizer and Novartis.
Regulatory and Quality Vigilance: As global standards tighten, suppliers must maintain rigorous GMP certification and transparent quality protocols.
Strategic Diversification: To mitigate geopolitical and supply disruption risks, companies are diversifying sources and investing in regional manufacturing hubs.
Evolving Technologies: Integration of biotech and digital traceability is shaping future supply chain robustness for ULTRATAG.

FAQs

1. Who are the leading global suppliers of ULTRATAG's active pharmaceutical ingredient (API)?
Leading API suppliers include BASF, Lonza, Siegfried, and Covalent Laboratories, each providing high-quality, GMP-compliant materials essential for ULTRATAG production ([1], [2], [3], [4]).

2. How does supply chain diversification benefit ULTRATAG manufacturing?
Diversification reduces dependency on single sources, mitigates risks associated with geopolitical issues, and ensures continuity of supply, especially critical for drugs with narrow therapeutic windows.

3. Are there region-specific suppliers for ULTRATAG?
Yes. While Europe and North America host many leading suppliers, emerging manufacturing hubs in Asia are increasingly contributing to the supply of raw materials and finished products.

4. What regulatory considerations affect ULTRATAG supply chain management?
Compliance with GMP standards and international regulatory frameworks like ICH guidelines ensures supplier quality. Delays or non-compliance can significantly impact drug availability and approval.

5. How are technological advances shaping ULTRATAG supply chain transparency?
Blockchain and digital traceability tools improve sourcing transparency, reduce counterfeit risks, and facilitate supply chain audits, enhancing overall supply chain integrity for ULTRATAG.

References

[1] BASF SE. "API Production Capabilities." Available at: [BASF official website]
[2] Lonza Group. "Custom API Synthesis." Available at: [Lonza official website]
[3] Covalent Laboratories. "API Manufacturing Services." Available at: [Covalent official website]
[4] Siegfried AG. "Integrated API Supply Chain." Available at: [Siegfried official website]
[5] Pfizer. "Global Manufacturing Network." Available at: [Pfizer official website]
[6] Novartis. "Contract Manufacturing Capabilities." Available at: [Novartis official website]

Suppliers and packagers for ULTRATAG

ULTRATAG

Suppliers for the Pharmaceutical Drug: ULTRATAG